IceCure Medical Ltd.
ICCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001584371
No open-market purchases or sales by IceCure Medical Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $544.7K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in IceCure Medical Ltd. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- 0 vs. Q2 2023
- Shares held
- 233.2K
- +76.9K (+49.2%) vs. Q2 2023
- Total value
- $127.3K
- −$54.0K (−29.8%) vs. Q2 2023
- New holders
- 5
- 3 more added
- Sold out
- 5
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ICCM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $544.7K |
| Q1 2026 | 18 | $976.8K |
| Q4 2025 | 19 | $318.7K |
| Q3 2025 | 17 | $298.2K |
| Q2 2025 | 18 | $247.0K |
| Q1 2025 | 14 | $153.8K |
| Q4 2024 | 13 | $168.7K |
| Q3 2024 | 15 | $117.9K |
| Q2 2024 | 14 | $267.5K |
| Q1 2024 | 12 | $120.1K |
| Q4 2023 | 17 | $312.0K |
| Q3 2023 | 12 | $127.3K |
| Q2 2023 | 12 | $181.3K |
| Q1 2023 | 9 | $88.5K |
| Q4 2022 | 11 | $245.0K |
| Q3 2022 | 9 | $85.3K |
| Q2 2022 | 10 | $174.4K |
| Q1 2022 | 10 | $171.6K |
| Q4 2021 | 13 | $2.31M |
| Q3 2021 | 7 | $3.34M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding IceCure Medical Ltd.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 72,634 | $40.3K | 0.00% | +72,634 | New |
| Bank of America Corp | 27,351 | $14.8K | 0.00% | −4,952−15.3% | Reduced |
| Virtu Financial LLC | 23,861 | $13.0K | 0.00% | +23,861 | New |
| Two Sigma Securities, LLC | 23,855 | $12.9K | 0.00% | +10,028+72.5% | Added |
| Barclays PLC | 18,100 | $9.78K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 15,504 | $8.60K | 0.00% | +15,504 | New |
| Susquehanna International Group Ltd. | 15,200 | $8.43K | 0.00% | −1,055−6.5% | Reduced |
| AE Wealth Management LLC | 15,000 | $8.10K | 0.00% | +5,000+50.0% | Added |
| UBS Group AG | 14,789 | $7.99K | 0.00% | +14,789 | New |
| JPMorgan Chase & Co | 5,950 | $3.30K | 0.00% | +5,950 | New |
| Tower Research Capital LLC (TRC) | 294 | $159 | 0.00% | +204+226.7% | Added |
| Royal Bank of Canada | 687 | $0 | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −18,900−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −5,670−100.0% | Sold out |
| Bartlett & Co. Wealth Management LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Bartlett & Co. LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |